Primer ID ultra-deep sequencing reveals dynamics of drug resistance-associated variants in breakthrough hepatitis C viruses: relevance to treatment outcome and resistance screening

2016 ◽  
Vol 21 (7) ◽  
pp. 567-577 ◽  
Author(s):  
Richard Barnard ◽  
Abha Chopra ◽  
Ian James ◽  
John Blinco ◽  
Mark W Watson ◽  
...  
Keyword(s):  
Drug Resistance ◽  
Treatment Outcome ◽  
Hepatitis C ◽  
Deep Sequencing ◽  
Resistance Screening ◽  
Hepatitis C Viruses ◽  
Breakthrough Hepatitis

Drug Resistance in Hepatitis C Virus: Future Prospects and Strategies to Combat It

2020 ◽  
Vol 30 (4) ◽  
pp. 323-336
Author(s):  
Iqra Almas ◽  
Samia Afzal ◽  
Hamna Imtiaz ◽  
Mahrukh Akbar Shaheen ◽  
Muhammad Daud ◽  
...  
Keyword(s):  
Drug Resistance ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Future Prospects

scholarly journals Relating serum GGT to ALT activity enhances its predictability on treatment outcome in chronic hepatitis C

Hepatology ◽  
2014 ◽  
Vol 59 (3) ◽  
pp. 1213-1214 ◽  
Author(s):  
Ahmad Amanzada ◽  
Giuliano Ramadori ◽  
Sabine Mihm
Keyword(s):  
Chronic Hepatitis ◽  
Treatment Outcome ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Alt Activity

Differences in treatment outcome for hepatitis C among ethnic groups

2004 ◽  
Vol 117 (3) ◽  
pp. 163-168 ◽  
Author(s):  
Matthew J Hepburn ◽  
Lisa M Hepburn ◽  
Norma S Cantu ◽  
Maria G Lapeer ◽  
Eric J Lawitz
Keyword(s):  
Treatment Outcome ◽  
Hepatitis C ◽  
Ethnic Groups

Molecular mechanisms of fitness compensation in drug resistance-associated NS3 protease variants in hepatitis C

2017 ◽  
Vol 66 (1) ◽  
pp. S319
Author(s):  
G. Dultz ◽  
T. Shimakami ◽  
I. Antes ◽  
S. Zeuzem ◽  
C. Lange ◽  
...  
Keyword(s):  
Drug Resistance ◽  
Hepatitis C ◽  
Molecular Mechanisms ◽  
Ns3 Protease
Sign in / Sign up

Export Citation Format

Share Document